0–3 years (n = 236) | 4–9 years (n = 229) | 10–18 years (n = 218) | P | |
---|---|---|---|---|
Sex (male) | 139 (58.9%)a | 113 (49.3%)b | 105 (48.1%)b | 0.04* |
Onset season | ||||
Spring | 49 (20.76%) | 50 (21.83%) | 55 (25.23%) | 0.318 |
Summer | 54 (22.88%) | 65 (28.38%) | 50 (22.94%) | |
Autumn | 70 (29.66%) | 53 (23.14%) | 47 (21.56%) | |
Winter | 63 (26.69%) | 61 (26.64%) | 66 (30.28%) | |
Family history positivity | 48 (20.34%) | 41 (17.90%) | 41 (18.81%) | 0.795 |
DKA positivity | 167 (70.76%)a | 134 (58.52%)b | 129 (59.17%)b | 0.009* |
DKA degree | ||||
Mild | 64 (38.32%) | 64 (47.76%) | 60 (46.51%) | 0.195 |
Moderate and severe | 103 (61.68%) | 70 (52.24%) | 69 (53.49%) | |
Term infant | 223 (94.5%)a | 194 (84.7%)b | 127 (58.3%)c | < 0.001* |
Breast milk before 6 months | 190 (80.5%) | 176 (76.9%) | 163 (74.8%) | 0.332 |
HbA1c (%) | 11.19 (2.44)a | 12.36 (2.47)b | 12.24 (3.09)b | < 0.001* |
C-peptide (nmol/L) | 0.31 (0.14,0.42)a | 0.52 (0.24,0.46)b | 0.74 (0.28,0.75)b | < 0.001* |
Blood glucose (mmol/L) | 23.43 (6.61)a | 22.94 (7.37)a | 20.36 (7.21)b | < 0.001* |
25OHD (ng/ml) | 20.73 (9.54)a | 17.79 (7.19)b | 17.08 (6.55)b | < 0.001* |
Hospital length of stay (days) | 15.88 (6.55)a | 14.32 (6.07)b | 11.60 (5.45)c | < 0.001* |
Disease course (days) | 5 (0,15.5) | 5 (0,15) | 4.5 (0,12) | 0.922 |
Cost (China Yuan) | 7481.52 (6166.42,10,495.78)a | 6819.28 (5304,8492.66)b | 6226.4 (4298.39,8570.15)b | < 0.001* |
Polydipsia | 206 (87.29%)a | 192 (83.84%)a | 155 (71.10%)b | 0.002* |
Polyuria | 191 (80.93%)a | 179 (78.17%)a | 124 (56.88%)b | < 0.001* |
Weight loss | 56 (23.73%)a | 93 (40.61%)b | 76 (34.86%)b | < 0.001* |
Delayed diagnosis | 83 (35.2%)a | 50 (21.8%)b | 41 (18.8%)b | < 0.001* |
ICA positivity | 2 (0.8%)a | 12 (5.2%)b | 14 (6.4%)b | < 0.001* |
IAA positivity | 42 (17.8%)a | 26 (11.3%)b | 96 (44%)c | < 0.001* |
GADA positivity | 140 (59.3%)a | 138 (60.2%)a | 68 (31.1%)b | < 0.001* |